Influenza Drugs Market
According to Intent Market Research, the Influenza Drugs Market is expected to grow from USD 1.1 Billion in 2024-e at a CAGR of 45.7% to touch USD 10.6 Billion by 2030. The Influenza Drugs Market is dominated by key players such as GlaxoSmithKline, Roche Holding AG, AbbVie Inc., Sanofi S.A., Mylan N.V. (Viatris Inc.), and Merck & Co., Inc.